SPHK1 and uveal melanoma: Specifically, in uveal melanoma, overexpression of both SPHK1 and SPHK2—the enzymes that catalyze the production of S1P—is associated with worse or unfavorable disease outcomes compared to the low-expression groups (Figure 3D).